[Pulmonary surfactant homeostasis associated genetic abnormalities and lung diseases]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Aug;33(4):564-8. doi: 10.3760/cma.j.issn.1003-9406.2016.04.031.
[Article in Chinese]

Abstract

Pulmonary surfactant (PS) is synthesized and secreted by alveolar epithelial type II (AEII) cells, which is a complex compound formed by proteins and lipids. Surfactant participates in a range of physiological processes such as reducing the surface tension, keeping the balance of alveolar fluid, maintaining normal alveolar morphology and conducting host defense. Genetic disorders of the surfactant homeostasis genes may result in lack of surfactant or cytotoxicity, and lead to multiple lung diseases in neonates, children and adults, including neonatal respiratory distress syndrome, interstitial pneumonia, pulmonary alveolar proteinosis, and pulmonary fibrosis. This paper has provided a review for the functions and processes of pulmonary surfactant metabolism, as well as the connection between disorders of surfactant homeostasis genes and lung diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • ATP-Binding Cassette Transporters / genetics
  • DNA-Binding Proteins / genetics
  • Homeostasis*
  • Humans
  • Lung Diseases / genetics*
  • Pulmonary Surfactant-Associated Protein C / genetics
  • Pulmonary Surfactants / metabolism*
  • Transcription Factors

Substances

  • ABCA3 protein, human
  • ATP-Binding Cassette Transporters
  • DNA-Binding Proteins
  • Pulmonary Surfactant-Associated Protein C
  • Pulmonary Surfactants
  • SFTPC protein, human
  • TTF1 protein, human
  • Transcription Factors